ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1349

Clinical Characteristics and Outcomes of Septic Bursitis

Sarah B. Lieber1, Clara Zhu2, Mary Louise Fowler3, Andrew Moore4, Robert H. Shmerling5 and Ziv Paz1, 1Beth Israel Deaconess Medical Center, Boston, MA, 2Medical School, Boston University School of Medicine, Boston, MA, 3School of Medicine, Boston University School of Medicine, Boston, MA, 4Medicine, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, 5Medicine, Beth Israel Deaconess Medical Center, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Infection

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Infection-related Rheumatic Disease: Poster Session

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Septic bursitis (SB) is a common condition that typically involves the olecranon and patellar bursae. It is unclear whether patients with SB treated surgically differ in their clinical presentation and outcomes from patients treated with antibiotics alone. Furthermore, it is unknown if preceding trauma is a risk factor for more severe disease and higher rates of surgical intervention. Finally, the factors distinguishing patients with olecranon SB from those with patellar involvement are not well understood. The purpose of this study is to describe the clinical features and outcomes of patients with SB and to address these uncertainties. 

Methods:

We conducted a retrospective cohort study of patients 18 years and older admitted to a single tertiary care center from 1998 to 2015 with culture-proven olecranon and patellar (including prepatellar and infrapatellar) SB. Patients with concurrent septic arthritis or sterile bursal fluid cultures were excluded. Baseline characteristics and clinical features, microbial profile, rate of operative intervention, length of hospital stay (LOS), and 60-day readmission rate were determined. Patients were stratified by site of SB, presence or absence of preceding bursal trauma, and operative or non-operative management.

Results:

Of 44 cases of SB, 31 involved the olecranon bursa and 13 affected the patellar bursae. Patients with olecranon and patellar SB were similar with respect to age, male predominance and frequency of preceding bursal trauma. However, patients managed operatively were younger (mean 42.4 vs. 57.7 years; p = 0.05), as were those without preceding bursal trauma (mean 51.1 vs. 62.6 years; p = 0.05). Clinical features at presentation and presence of comorbidities were similar when patients were stratified by site of SB, history of preceding bursal trauma, or management strategy. The most common organisms isolated from bursal fluid were methicillin-sensitive Staph aureus (MSSA), methicillin-resistant Staph aureus (MRSA), and coagulase negative Staph. Patients managed operatively were discharged to rehabilitation less frequently (p=0.04) and had a lower rate of 60-day readmission than their conservatively managed peers (p = 0.05). A trend toward shorter mean LOS was observed among patients with preceding bursal trauma as compared to those without trauma (4.4 vs. 10.4 days; p = 0.07).

Conclusion:

In this study of SB, we were unable to identify factors that differentiate patients treated surgically from those treated conservatively. Similarly, there was no clear relationship between preceding trauma or site of SB and clinical course, management, or outcomes. Patients with SB treated surgically tended to be younger and have lower readmission rates. Additional study is needed to identify patients who would benefit from early surgical intervention for SB.


Disclosure: S. B. Lieber, None; C. Zhu, None; M. L. Fowler, None; A. Moore, None; R. H. Shmerling, None; Z. Paz, None.

To cite this abstract in AMA style:

Lieber SB, Zhu C, Fowler ML, Moore A, Shmerling RH, Paz Z. Clinical Characteristics and Outcomes of Septic Bursitis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/clinical-characteristics-and-outcomes-of-septic-bursitis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-and-outcomes-of-septic-bursitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology